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Background
The autoimmune lymphoproliferative syndrome (ALPS)
is a genetic disorder of lymphocyte apoptosis. ALPS is
characterized by childhood onset of lymphadenopathy,
hepatosplenomegaly, autoimmune cytopenias, elevated
(>1,5%) double negative T (DNT; CD3+TCRab+CD4-
CD8-) lymphocytes in peripheral blood and an increased
risk of lymphoma.
Most cases (>65%), known as ALPS type Ia, are asso-
ciated with dominant heterozygous germline mutations
in the TNFRSF6 gene encoding the protein for CD95
(Fas). Other genes are implicated in different ALPS sub-
types (TNFSF6-Fas ligand, CASP8, CASP10 and N-RAS).
Methods
We studied 32 individuals from different Spanish Hospi-
tals. Selected ALPS patients meet Clinical (lymphadeno-
pathy, splenomegaly and/or cytopenias) and Laboratory
(hyper-gammaglobulinemia and elevated DNT cells) cri-
teria. TNFRSF6 gene was analyzed by DNA sequencing
in every patient. In selected cases, without TNFRSF6
mutation, TNFSF6 (Fas ligand), CASP-8 (caspase-8),
CASP-10 (caspase-10), N-RAS and FADD genes were
further evaluated by sequencing.
Results
26 patients were found to be heterozygous for a single
TNFRSF6 mutation (ALPS Ia).
Seven different alterations were identified affecting
exons 2, 8 and 9. Four of these mutations have been not
previously described (p.E20X, p.Y216fsX13, p.L226P and
p.D210N). The mutations include insertions, splicing
defects, missense and nonsense substitutions. The rest
of the patients do not have any mutation in TNFRSF6,
TNFSF6 or CASP-10 genes. Hence, they were classified
as ALPS III. As compared to controls and healthy rela-
tives bearing the same genetic alterations, ALPS Ia
patients demonstrated significantly higher IL-10 and Igs
serum levels, especially IgE. Those markers were also
elevated in ALPS III patients but in a less remarkable
fashion.
Conclusions
The combination of elevated DNT counts (>1,5%) with
i n c r e a s e dI L - 1 0a n dI g Es e r u ml e v e l si ss t r o n g l yl i n k e d
with clinical presentation in FAS mutation-bearing indi-
viduals, whereas isolated high DNT percentage is usually
the only altered parameter in healthy carriers from the
same families. This enable the targeting of patients with
clinical features of ALPS to have a more directed eva-
luation, particularly in regard to DNA sequencing for
FAS mutations and other apoptosis-related genes. Sev-
eral novel FAS mutations were found and characterized
in Spanish ALPS patients.
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